Home

Nidan Laboratories & Healthcare PE Ratio

Image

Nidan Laboratories & Healthcare Ltd

NSE: NIDAN

PE

14.4

Last updated on: Jul 05, 2025

Key Highlights

  • The P/E Ratio of Nidan Laboratories & Healthcare Ltd is 14.4 as of 05 Jul 15:30 PM .
  • The P/E Ratio of Nidan Laboratories & Healthcare Ltd changed from 17.3 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Nidan Laboratories & Healthcare Ltd is ₹ 20.4 as of 04 Jul 15:30 .
  • The PE Ratio of Healthcare Industry has changed from 35.5 to 62.3 in 5 years. This represents a CAGR of 11.91%.
  • The PE Ratio of Automobile industry is 14.5. The PE Ratio of Finance industry is 25.8. The PE Ratio of Healthcare industry is 49.0. The PE Ratio of IT - Software industry is 26.8. The PE Ratio of Retail industry is 116.4. The PE Ratio of Textiles industry is 21.8 in 2025.

Historical P/E Ratio of Nidan Laboratories & Healthcare Ltd

No data available

Company Fundamentals for Nidan Laboratories & Healthcare Ltd

Image

Nidan Laboratories & Healthcare Ltd

NSE: NIDAN

Share Price

₹ 20.4

-0.20 (-0.97%)

stock direction

Last updated on: Jul 04, 2025

Market Price of Nidan Laboratories & Healthcare Ltd

1M

1Y

3Y

5Y

Monitoring Nidan Laboratories & Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Jul 202520.4
03 Jul 202520.6
02 Jul 202520.6
01 Jul 202520.6
30 Jun 202521.35
27 Jun 202521.75
26 Jun 202520.8
25 Jun 202520.5
24 Jun 202520
23 Jun 202520.1

SWOT Analysis Of Nidan Laboratories & Healthcare Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Nidan Laboratories & Healthcare Ltd

Asset Value vs Market Value of Nidan Laboratories & Healthcare Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Nidan Laboratories & Healthcare Ltd28.36
Max Healthcare Institute Ltd126141
Apollo Hospitals Enterprise Ltd108619
Fortis Healthcare Ltd60895
Narayana Hrudayalaya Ltd41090
Aster DM Healthcare Ltd32813

PE Ratio of Nidan Laboratories & Healthcare Ltd Explained

28.36

Market cap

2

Earnings

14.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Nidan Laboratories & Healthcare Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Nidan Laboratories & Healthcare Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Nidan Laboratories & Healthcare Ltd

No data available

* All values are in %

About Nidan Laboratories & Healthcare Ltd

  • Nidan Laboratories & Healthcare Limited was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra.
  • Subsequently, Company name was changed from 'Abhi Diagnostic Imagings Private Limited' to 'Nidan Laboratories And Healthcare Private Limited' and obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra.
  • Subsequently, the status if the Company was converted into a Public Limited and name of the Company was changed to Nidan Laboratories And Healthcare Limited' and a fresh Certificate of Incorporation upon the conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021.

Nidan Laboratories & Healthcare Ltd News Hub

Nidan Laboratories & Healthcare to convene AGM

Nidan Laboratories & Healthcare announced that the 24th Annual General Meeting (AGM) of the company

Read more

06 Sept 24

Nidan Laboratories & Healthcare to conduct board meeting

Nidan Laboratories & Healthcare will hold a meeting of the Board of Directors of the Company on 14 N

Read more

12 Nov 24

Nidan Laboratories & Healthcare declare Quarterly Result

Nidan Laboratories & Healthcare will hold a meeting of the Board of Directors of the Company on 28 M

Read more

23 May 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Nidan Laboratories & Healthcare Ltd

What is the current PE Ratio of Nidan Laboratories & Healthcare Ltd?

The Current PE Ratio of Nidan Laboratories & Healthcare Ltd is 14.37 as on 5 Jul 2025.

What is the average PE Ratio of the Healthcare industry?

The average industry PE Ratio of Healthcare is 49.0 as on 5 Jul 2025.

What was the PE Ratio of Nidan Laboratories & Healthcare Ltd last year?

The PE Ratio of Nidan Laboratories & Healthcare Ltd was 13.27 last year, now the PE ratio is 14.37, showing a year-on-year growth of 8.3%.

What does the PE Ratio of Nidan Laboratories & Healthcare Ltd indicate about its stock?

The PE Ratio of Nidan Laboratories & Healthcare Ltd is 14.37. This ratio indicates that investors are willing to pay 14.37 times the earnings per share for each share of Nidan Laboratories & Healthcare Ltd.

What is the PE Ratio Growth of Nidan Laboratories & Healthcare Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Nidan Laboratories & Healthcare Ltd grew by 8.3% whereas, the EPS ratio grew by 65.5.

How does the PE ratio of Nidan Laboratories & Healthcare Ltd compare to industry peers?

The PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Nidan Laboratories & Healthcare Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Nidan Laboratories & Healthcare Ltd PE Ratio.

What factors influence the PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio?

The PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Nidan Laboratories & Healthcare Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio?

You can check the latest PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Nidan Laboratories & Healthcare Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Nidan Laboratories & Healthcare Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Nidan Laboratories & Healthcare Ltd PE Ratio predict future stock performance?

While the Nidan Laboratories & Healthcare Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions